Get started
Author

Meghana Chennupati

Observed institution: Squad Medicine and Research (SMR)
OpenAlex ID: A5114423680
ABCL-614: Circulating Tumor DNA as a Biomarker for Minimal Residual Disease and Early Relapse Detection in Diffuse Large B-Cell Lymphoma: A Systematic Review
2025 · Srilasya Pamidi, Nischitha Vallurupalli, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
MCL-1190: Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review
2026 · Snigdha Mandava, Meghana Chennupati, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: MCL-1190: Therapeutic Implications of TP53 and High-Risk Genomic Alterations in Mantle Cell Lymphoma: A Systematic Review
2026 · Snigdha Mandava, Meghana Chennupati, et al. · Clinical Lymphoma Myeloma & Leukemia
Association Between Type 2 Diabetes Mellitus and Cognitive Impairment Among Indian Population: A Systematic Review and Meta-analysis (P6-7.011)
2026 · Sai Lavanya Patnala, Meghana Chennupati, et al. · Neurology
Diagnostic Accuracy of Artificial Intelligence for Intracranial Hemorrhage Detection on Non-contrast CT: A Systematic Review and Meta-analysis (P9-4.010)
2026 · Meghana Chennupati, Shradha Kakde, et al. · Neurology
Immune-mediated Neurological Syndromes Following Neurotropic Viral Infections: Clinical, Immunopathological, and Therapeutic Insights (P7-3.008)
2026 · Amritaa Thalla, Aadhiti Kandula, et al. · Neurology
Comparative Efficacy and Safety of Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials (P8-4.003)
2026 · Meghana Chennupati, Shradha Kakde, et al. · Neurology
Network Meta-analysis of Atzumi (STS101) Dihydroergotamine Nasal Powder Versus Modern Oral and Intranasal Agents for the Acute Treatment of Migraine (P8-15.016)
2026 · Alishan Sardar, Meghana Chennupati, et al. · Neurology
Neural Network-assisted Prediction of Venous Thromboembolism after Spine and Neurological Operations - NeuroVeT Study (P3-19.008)
2026 · Sanjana Avajigari, Shradha Kakde, et al. · Neurology
Diagnostic Accuracy of ESR, CRP, and Platelet Count (and Their Combinations) for Giant Cell Arteritis: A Meta-analysis of 14,000 Patients (P5-2.005)
2026 · Sharath Chandra Anne, Shradha Kakde, et al. · Neurology
Comparative Efficacy and Safety of CGRP Monoclonal Antibodies and Oral Gepants for Migraine Prevention: Evidence from Randomized Controlled Trials and Network Meta-analysis (P10-15.014)
2026 · Sharath Chandra Anne, Shradha Kakde, et al. · Neurology
Comparative Efficacy and Safety of Antipsychotics for Parkinson’s Disease Psychosis: A Systematic Review and Network Meta-Analysis
2025 · Sai Sahithi Reddy Atla, Praveen Gunasekaran, et al. · medRxiv
PDF
POSTER: AML-609 Efficacy and Safety of FLT3 Inhibitors in Combination With Intensive Chemotherapy in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia: A Systematic Review
2025 · Gowrishankar Palaniswamy, Swetha Chinthala, et al. · Clinical Lymphoma Myeloma & Leukemia
MM-604: Efficacy and Safety of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review of Clinical Trials
2025 · Meghana Chennupati, Aadithi Kandula, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-593: Clinical Outcomes, Challenges, and Outcomes of Indigenous CD19-Directed CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in India: A Systematic Review
2025 · Snigdha Mandava, Tarun Kumar Suvvari, et al. · Clinical Lymphoma Myeloma & Leukemia
AML-609: Efficacy and Safety of FLT3 Inhibitors in Combination With Intensive Chemotherapy in Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia: A Systematic Review
2025 · Gowrishankar Palaniswamy, Swetha Chinthala, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: CT-593 Clinical Outcomes, Challenges, and Outcomes of Indigenous CD19-Directed CAR T-Cell Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in India: A Systematic Review
2025 · Snigdha Mandava, Tarun Kumar Suvvari, et al. · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-614 Circulating Tumor DNA as a Biomarker for Minimal Residual Disease and Early Relapse Detection in Diffuse Large B-Cell Lymphoma: A Systematic Review
2025 · Srilasya Pamidi, Nischitha Vallurupalli, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 18
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type